Veliparib in combination with carboplatin for the treatment of triple negative breast cancer
Номер патента: PH12016501101A1
Опубликовано: 11-07-2016
Автор(ы): Gordon Gary
Принадлежит: AbbVie Inc
Опубликовано: 11-07-2016
Автор(ы): Gordon Gary
Принадлежит: AbbVie Inc
Реферат: The invention relates to a method for the treatment of triple negative breast cancer in a subject, comprising administering to the subject an effective amount of 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, or a pharmaceutically acceptable salt thereof, and an effective amount of carboplatin, in combination with standard of care.
Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
Номер патента: US09623009B2. Автор: QIN Qin,Vincent Giranda,Gary Gordon,Jane Qian,Mark D. MCKEE. Владелец: AbbVie Inc. Дата публикации: 2017-04-18.